# CCS Associates, Inc. Canonical: https://abierto.us/vendors/ccs-associates-inc-vcnrs52g5pg7 - UEI: VCNRS52G5PG7 - CAGE: 3H9A1 - Location: San Jose, CA - Awards in window: 22 (57 transactions), $14,492,356 obligated, January 23, 2024 to August 31, 2026 ## Awarding agencies - National Institutes of Health: 21 awards, $14,492,356 - Food and Drug Administration: 1 awards, $0 ## Industries - 541690 Other Scientific and Technical Consulting Services: $14,457,206 - 541990 All Other Professional, Scientific, and Technical Services: $75,077 - 541712 Professional, Scientific, and Technical Services: -$10,521 - 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$29,406 ## Competition - Full and Open Competition After Exclusion of Sources: 11 awards - Full and Open Competition: 6 awards - Competed Under SAP: 5 awards ## Largest awards - 75N91023C00054 (definitive contract): $9,437,240, NIH NCI. The Purpose of This Requirement Is to Provide Regulatory Services and Technical Support to the Division of Cancer Prevention (Dcp) at the National Cancer Institute (Nci). NCI and DCP Have a Recurring Requirement for Regulatory Services and Technical. https://www.usaspending.gov/award/CONT_AWD_75N91023C00054_7529_-NONE-_-NONE-/ - 75N91023C00055 (definitive contract): $3,751,484, NIH NCI. The Purpose of the Acquisition Is to Provide a Variety of Critical Cancer Prevention Information Management Functions Necessary to Support the Identification, Development, and Qualification of Potential Cancer Preventive Agents for Investigational NE. https://www.usaspending.gov/award/CONT_AWD_75N91023C00055_7529_-NONE-_-NONE-/ - 75N95025F00001 (delivery order): $394,539, National Institutes of Health Nida. Regulatory Preparation, Review, and Submission for Clinical Trials Associated with Nida Drug Supply Program. N01DA-23-8933. April 1, 2025 to March 31, 2026. https://www.usaspending.gov/award/CONT_AWD_75N95025F00001_7529_75N95023D00025_7529/ - 75N95026F00001 (delivery order): $335,910, National Institutes of Health Nida. Regulatory Preparation, Review, and Submission for Clinical Trials Associated with Nida Drug Supply Program. N01DA-23-8933. March 27, 2026 to March 26, 2027. https://www.usaspending.gov/award/CONT_AWD_75N95026F00001_7529_75N95023D00025_7529/ - 75N95024F00001 (delivery order): $307,737, National Institutes of Health Nida. Regulatory Affairs Support. CCS Associates, INC. N01DA-23-8933. April 1, 2024 to March 31, 2025. https://www.usaspending.gov/award/CONT_AWD_75N95024F00001_7529_75N95023D00025_7529/ - 75N95023P00808 (purchase order): $271,701, National Institutes of Health Nida. Regulatory Affairs Consulting Support Services. https://www.usaspending.gov/award/CONT_AWD_75N95023P00808_7529_-NONE-_-NONE-/ - 75N95025F00001 (delivery order): $230,617, National Institutes of Health Nida. New Sow for Regulatory Activities for Pcca and Mmab Gene Therapy Products. https://www.usaspending.gov/award/CONT_AWD_75N95025F00001_7529_75N95022D00013_7529/ - 75N98026F00001 (delivery order): $159,116, National Institutes of Health Olao. Regulatory Support for Lead Gene Therapy Candidates as a Treatment for Congenital Myasthenic Syndromes. https://www.usaspending.gov/award/CONT_AWD_75N98026F00001_7529_75N95022D00013_7529/ - 75N95023P00692 (purchase order): $154,331, National Institutes of Health Nida. Medical Writing Consulting Services. https://www.usaspending.gov/award/CONT_AWD_75N95023P00692_7529_-NONE-_-NONE-/ - 75F40121C00165 (definitive contract): $0, FDA Office of Acq Grant SVCS. The Contractor Shall Provide the Following Tasks/Deliverables Over the Course of the Contract.. https://www.usaspending.gov/award/CONT_AWD_75F40121C00165_7524_-NONE-_-NONE-/ - 75N93021D00040: $0, National Institutes of Health Niaid. The Purpose of This Modification Is to Revise Section J. List of Attachments, Item 1. Statement of Work. the Revision Removes Language Limiting Support to the National Institute of Allergy and Infectious Diseases (Niaid) and Expands the Scope of the. https://www.usaspending.gov/award/CONT_IDV_75N93021D00040_7529/ - 75N95022D00013: $0, National Institutes of Health Nida. EO14398 Cro Support for Ncats Regulatory Affairs Support and Related Services. https://www.usaspending.gov/award/CONT_IDV_75N95022D00013_7529/ - 75N95023D00025: $0, National Institutes of Health Nida. Regulatory Affairs Support. CCS Associates, INC. N01DA-23-8933. September 20, 2023 to September 19, 2028.. https://www.usaspending.gov/award/CONT_IDV_75N95023D00025_7529/ - 75N95022F00002 (delivery order): -$281, National Institutes of Health Nida. FY26 Udo Initiative Regulatory Support for Preparation and Filing of a Pre-Investigational New Drug (Pre-Ind) Application with the Food and Drug Administration (Fda) for Clinical Development of Mitragynine (Mg).. https://www.usaspending.gov/award/CONT_AWD_75N95022F00002_7529_75N95022D00013_7529/ - 75N95022F00001 (delivery order): -$1,457, National Institutes of Health Nida. FY26 Udo Initiative Preparation of an Investigational New Drug (Ind) Application with Food and Drug Administration (Fda) for a Treatment for Jansen'S Metaphyseal Chondrodysplasia. https://www.usaspending.gov/award/CONT_AWD_75N95022F00001_7529_75N95022D00013_7529/ - 75N95020P00589 (purchase order): -$2,038, National Institutes of Health Nida. FY26 Udo Initiative Medical Writing Consulting and Drug Dossier Development Support Services. https://www.usaspending.gov/award/CONT_AWD_75N95020P00589_7529_-NONE-_-NONE-/ - HHSN268201400001C (definitive contract): -$10,521, National Institutes of Health Nhlbi. Vita 2 - Administrative Coordinating Center. https://www.usaspending.gov/award/CONT_AWD_HHSN268201400001C_7529_-NONE-_-NONE-/ - HHSN271201500084C (definitive contract): -$19,175, National Institutes of Health Nida. Ninds BPN Medical Writing Consultant. https://www.usaspending.gov/award/CONT_AWD_HHSN271201500084C_7529_-NONE-_-NONE-/ - 75N93024F00001 (delivery order): -$29,406, National Institutes of Health Niaid. To De-Obligate Remaining Funds and Administratively Close the Task Order.. https://www.usaspending.gov/award/CONT_AWD_75N93024F00001_7529_75N93021D00040_7529/ - 75N91018C00030 (definitive contract): -$57,735, NIH NCI. Technical Information Research for Cancer Preventive Agent Development. Period of Performance: 09/30/2022 - 09/29/2023. https://www.usaspending.gov/award/CONT_AWD_75N91018C00030_7529_-NONE-_-NONE-/ - HHSN271201700070C (definitive contract): -$194,586, National Institutes of Health Nida. Regulatory Affairs Support. https://www.usaspending.gov/award/CONT_AWD_HHSN271201700070C_7529_-NONE-_-NONE-/ - 75N91018C00017 (definitive contract): -$235,119, NIH NCI. Regulatory Support for Cancer Prevention Agent Development. https://www.usaspending.gov/award/CONT_AWD_75N91018C00017_7529_-NONE-_-NONE-/ --- Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/ccs-associates-inc-vcnrs52g5pg7.